Serial Number
79417239
Owner
PROVEPHARM LIFE SOLUTIONSAttorney
Kaitlyn M. GarvinFiling Date
Nov 8, 2024
ACT TO IMPROVE LIFE PROVEPHARM Trademark
Serial Number: 79417239 • Registration: 7989149
Trademark Classes
Owner Contact Info
22, RUE MARC DONADILLE
MARSEILLE 13013 , FR
Entity Type: 33
Legal Representation
Correspondence Address
Kaitlyn M. Garvin Saunders & Silverstein LLP
14 Cedar Street, Suite 224
Amesbury, MA 01913
United States
Trademark Details
Filing Date
November 8, 2024
Registration Date
October 21, 2025
Published for Opposition
September 2, 2025
Goods & Services
Chemical products in the nature of chemicals for use in industry and science; raw methylene blue for scientific or research use; chemical additives for use in manufacture of pharmaceuticals; proteins in raw material form for scientific and medical research; proteins used in manufacturing processes; chemical additives, namely, emulsifiers, vitamins, antioxidants, additives, emollients and proteins for manufacture of cosmetics; plant hormones being phytohormones; vitamins for manufacturing pharmaceutical products; stabilizing chemical agents, namely, enzyme stabilizers for vitamins
Clinical medical reagents; synthetic peptides for the treatment of blood poisoning for pharmaceutical use; medicines to treat conditions of the leg, hoof, ear, nose and throat for animals; vitamins for animals; medicated foams, oils, lotions, creams, balms, ointments, gels and milks for the treatment of skin for pharmaceutical, medical and veterinary use; phytotherapy preparations for medical use; vitamins and vitamin preparations; pharmaceutical diagnostic preparations for medical purposes for marking tissues by injection in surgery and in internal medicine; chemical products, namely, surgical dyes for medical use for marking tissues by injection in surgery and in internal medicine; injectable pharmaceutical solutions for use as radio-isotope markers for diagnostic use in surgical procedures; drug delivery agents in the form of vials in the nature of ampoules sold filled with injectable pharmaceutical solutions that facilitate delivery of pharmaceutical preparations; pre-filled syringes sold filled with antidotes for medical and clinical use and sold filled with injectable pharmaceutical, namely, surgical dyes for marking tissues by application in surgery and internal medicine; methylene blue to treat methemoglobinemia for medical use; methylene blue solutions, namely, surgical dyes for medical use; indigo carmine, namely, surgical dyes for medical use; indigo cumin solutions, namely, surgical dyes for medical use